Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for ...
TELA Bio launches larger sizes of OviTex PRS for plastic and reconstructive surgery: Malvern, Pennsylvania Wednesday, April 2, 2025, 17:00 Hrs [IST] TELA Bio, Inc, a commercial-st ...
14h
MyChesCo on MSNTELA Bio Expands OviTex PRS Line with Larger Surgical SizesTELA Bio, Inc. (NASDAQ: TELA) has announced the U.S. launch of larger configurations for its OviTex PRS Reinforced Tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results